Stocks and InvestingStocks and Investing
Thu, February 29, 2024
Wed, February 28, 2024

Douglas Tsao Reiterated (APLS) at Strong Buy and Held Target at $92 on, Feb 28th, 2024


Published on 2024-10-28 09:17:08 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $92 on, Feb 28th, 2024.

Douglas has made no other calls on APLS in the last 4 months.



There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 2 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Graig Suvannavejh of "Mizuho" Maintained at Hold with Increased Target to $60 on, Friday, February 16th, 2024
  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $54 on, Thursday, December 14th, 2023


These are the ratings of the 8 analyists that currently disagree with Douglas


  • Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $79 on, Tuesday, January 30th, 2024
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $75 on, Wednesday, January 24th, 2024
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $67 on, Friday, December 15th, 2023
  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $85 on, Tuesday, December 5th, 2023